Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Greenwich LifeSciences, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2025 | 1 | -$0.24 | -$0.24 | -$0.24 |
| Q3 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
| Q4 2025 | 1 | -$0.23 | -$0.23 | -$0.23 |
Greenwich LifeSciences, Inc. Earnings Date And Information
Greenwich LifeSciences, Inc. last posted its earnings results on Tuesday, April 15th, 2025. The company reported $-0.61 earnings per share for the quarter, missing analysts' consensus estimates of $-0.21 by $0.4. The company had revenue of 3,612 for the quarter and had revenue of 0 for the year. Greenwich LifeSciences, Inc. has generated $-1 earnings per share over the last year ($-1.21 diluted earnings per share) and currently has a price-to-earnings ratio of -7.94. Greenwich LifeSciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 19th, 2025 based on prior year's report dates.
Greenwich LifeSciences, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 04/15/2025 | Q4 2024 | -$0.21 | -$0.62 | -0.41 | $3,612 | $3,612 |
| 11/14/2024 | Q3 2024 | -$0.21 | -$0.20 | 0.01 | $0 | $0 |
| 08/14/2024 | Q2 2024 | -$0.20 | -$0.20 | 0 | $0 | $0 |
| 05/20/2024 | Q1 2024 | N/A | -$0.19 | N/A | N/A | $0 |
| 04/15/2024 | Q4 2023 | -$0.20 | -$0.21 | -0.01 | N/A | $5,418 |
| 10/19/2023 | Q3 2023 | -$0.22 | -$0.19 | 0.03 | N/A | $0 |
| 08/21/2023 | Q2 2023 | -$0.23 | -$0.13 | 0.1 | N/A | $0 |
| 05/22/2023 | Q1 2023 | N/A | -$0.16 | N/A | N/A | $0 |
| 03/31/2023 | Q4 2022 | -$0.23 | -$0.21 | 0.02 | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$0.19 | -$0.18 | 0.01 | N/A | $0 |
| 08/15/2022 | Q2 2022 | -$0.19 | -$0.06 | 0.13 | N/A | $0 |
| 05/20/2022 | Q1 2022 | -$0.19 | -$0.15 | 0.04 | N/A | $0 |
| 03/21/2022 | Q4 2021 | -$0.07 | -$0.18 | -0.11 | N/A | $0 |
| 11/15/2021 | Q3 2021 | -$0.06 | -$0.07 | -0.01 | N/A | $0 |
| 08/13/2021 | Q2 2021 | N/A | -$0.06 | N/A | N/A | $0 |
| 05/20/2021 | Q1 2021 | -$0.26 | -$0.05 | 0.21 | N/A | $0 |
| 03/31/2021 | Q4 2020 | -$0.93 | -$0.13 | 0.8 | N/A | $0 |
| 11/16/2020 | Q3 2020 | N/A | -$0.02 | N/A | N/A | $0 |
| 06/29/2020 | Q2 2020 | N/A | -$0.02 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$0.02 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Greenwich LifeSciences, Inc. Earnings: FAQ's
Greenwich LifeSciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, May 19th, 2025 based offlast year's report dates.
The conference call for Greenwich LifeSciences, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Greenwich LifeSciences, Inc.'s latest earnings report can be read online.
Greenwich LifeSciences, Inc. (:GLSI) has a recorded net income of $-15,788,809.Greenwich LifeSciences, Inc. has generated $-1.21 earnings per share over the last four quarters.
Greenwich LifeSciences, Inc. (:GLSI) has a price-to-earnings ratio of -7.94 and price/earnings-to-growth ratio is 0.15.